Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course

Research output: Contribution to journalJournal articleResearchpeer-review

  • Mohsen Khademi
  • Ingrid Kockum
  • Magnus L Andersson
  • Ellen Iacobaeus
  • Lou Brundin
  • Sellebjerg, Finn Thorup
  • Jan Hillert
  • Fredrik Piehl
  • Tomas Olsson
Levels of CXCL13, a potent B-cell chemoattractant, are elevated in the cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of MS activity. Levels decrease upon effective treatments.
Original languageEnglish
JournalMultiple Sclerosis
Volume17
Issue number3
Pages (from-to)335-43
Number of pages9
ISSN1352-4585
DOIs
Publication statusPublished - 2011

ID: 40194240